Savers Value Village (SVV) Insider Exercise and 10b5-1 Sale of 9,052 Shares

Rhea-AI Filing Summary

Richard A. Medway, General Counsel of Savers Value Village, Inc. (SVV), executed option exercises and sales on 09/24/2025. He exercised 9,052 options with an exercise price of $1.41 per share, converting them into the same number of common shares. Those 9,052 shares were then sold under a 10b5-1 trading plan at a weighted average price of $13.0415 per share (execution range $12.98–$13.20). After these transactions the reporting person held 0 shares of common stock directly and reported 384,256 shares of beneficial ownership (per the filing). The filing explains the option grant schedule and that some options are performance-based and time-based.

Positive

• Transaction disclosed under a 10b5-1 plan, indicating prearranged trading and enhanced compliance transparency
• Full exercise and sale details provided: exercise price ($1.41), weighted average sale price ($13.0415) and execution range ($12.98–$13.20)
• Filing explains vesting structure for options, including time-based and performance-based components

Negative

• Insider sale of 9,052 shares reduced direct common stock holdings to 0, which some investors may view unfavorably

Insights

Securities Analyst

TL;DR: Insider exercised vested options and promptly sold those shares under a prearranged 10b5-1 plan; reporting and disclosures appear complete.

The filing shows a routine option exercise and immediate sale of 9,052 shares executed under a 10b5-1 plan, with a disclosed weighted average sale price and price range. The options exercised carried a low exercise price ($1.41) relative to the sale price (~$13.04), indicating a substantial gain on those specific shares. The form also discloses the larger pool of beneficially owned shares (384,256) and clarifies vesting mix between time-based and performance-based awards. For investors, this is a standard insider liquidity event rather than an operational disclosure. Documentation of the 10b5-1 plan and price-range detail supports compliance and transparency.

Corporate Governance Expert

TL;DR: Disclosure is clear about the 10b5-1 plan and option vesting; no governance red flags in the filing itself.

The Form 4 specifies the 10b5-1 adoption date (March 10, 2025), provides the weighted average sale price and execution range, and explains vesting mechanics for the underlying options (time-based and performance-based components). The reporting person signed the form and included explanatory notes on option origin and vesting, which aligns with best practices for insider transaction transparency. The immediate sale following exercise is disclosed and tied to the pre-existing plan, mitigating concerns about opportunistic trading based on nonpublic information as presented here.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Medway Richard A.

(Last) (First) (Middle)

C/O SAVERS VALUE VILLAGE, INC.

11400 SE 6TH, SUITE 125

(Street)

BELLEVUE WA 98004

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Savers Value Village, Inc. [ SVV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Counsel

3. Date of Earliest Transaction (Month/Day/Year)
09/24/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/24/2025		M		9,052	A	$1.41	9,052	D
Common Stock	09/24/2025		S(1)		9,052	D	$13.0415(2)	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (Right to Purchase)(3)	$1.41	09/24/2025		M			9,052	(4)	06/12/2029	Common Stock	9,052	$1.41	384,256(5)	D

Explanation of Responses:

1. The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 10, 2025.

2. This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $12.98 to $13.20. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

3. Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions.

4. The June 12, 2019 stock option grant vested in substantially equal annual installments over five years starting March 28, 2020, and was fully vested on March 28, 2024.

5. Approximately 16% represents time-based options which vested in substantially equal annual installments over five years starting March 28, 2020, and approximately 84% represents performance-based options, of which 25% vested upon the initial public offering and the remainder will be eligible for vesting upon satisfaction of certain performance criteria including stock price performance.

Remarks:

	/s/ Richard Medway	09/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did SVV insider Richard Medway do on 09/24/2025?

He exercised 9,052 options at an exercise price of $1.41 and sold those 9,052 shares under a 10b5-1 trading plan at a weighted average price of $13.0415.

How many shares does Medway beneficially own after the reported transactions?

The filing reports 0 shares owned directly after the sale and a reported beneficial ownership of 384,256 shares.

Was the sale part of an automatic trading plan?

Yes. The sale was executed pursuant to a 10b5-1 plan adopted on March 10, 2025.

What price range were the sold shares executed at?

The filing states the shares were executed at prices ranging from $12.98 to $13.20 per share, with a weighted average of $13.0415.

What options were exercised?

Options granted under the Registrant's 2019 Management Incentive Plan were exercised; the specific grant vested over five years starting March 28, 2020, and was fully vested on March 28, 2024.